You are subscribed to the Ophthalmology Times eNews.

Glaucoma 360
Twitter Facebook

View Online  |  Download Magazine  |  Share With A Colleague  |  Print & Digital Subscribe  |  eNewsletter Subscribe

WELCOME TO GLAUCOMA 360

February 6, 2015

Ophthalmology Times welcomes attendees and readers to the 4th Annual Glaucoma 360, a series of three events uniting research, industry, and philanthropy with one mission to find a cure for glaucoma.

TODAY'S HIGHLIGHTS

Glaucoma 360 unites ophthalmology in one direction for a cure

The Glaucoma Research Foundation kicked off its 4th Annual Glaucoma 360 meeting, a series of three events over this weekend that unites clinicians, researchers, members of industry, and philanthropy with one mission. Find out more about this year's program

GRF presents Catalyst, Visionary Awards to leaders in medicine, science

Glaucoma Research Foundation (GRF) honored a long-time global leader in ophthalmology with its Catalyst Award on Thursday night at the foundation’s Glaucoma 360 Annual Gala and presented two renowned stem-cell researchers with its Visionary Award. Find out who was recognized

Andras Komáromy, PhD, wins Shaffer Award for research of gene therapy to control IOP

The Shaffer Prize, presented annually by GRF, recognizes a researcher whose project best exemplifies the pursuit of innovative ideas in the quest to better understand glaucoma. Learn more about this year's recipient and his research

While attending the Glaucoma 360 events, stay connected by using and following
#Glaucoma360

Ophthalmology Times @OphthTimes

Joel Schuman, MD, discusses #Glaucoma 360 and the Catalyst for a Cure http://bit.ly/1Kebbtk

Glaucoma Research @GlaucomaOrg

We're thrilled to have Richard Lindstrom, MD and Thomas Samuelson, MD of @MinnesotaEye moderating panels at #Glaucoma360 on Feb 6. #Glaucoma

Top Tweets

We welcome your feedback!
Please send your comments to:

Mark L. Dlugoss

Group Content Director

UBM Advanstar Eyecare Group

mdlugoss@advanstar.com

DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times.
The sponsors do not endorse and are not responsible for the accuracy of the content or for practices or standards of non-sponsor sources. These articles may discuss regimens that have not been approved by the FDA.
For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences, please see the appropriate manufacturer's product circular.

Editorial Questions? Contact the Editorial Team Click Here. Sales, Reprints, Classified questions? Contact the Sales Team Click Here.

ModernMedicine logoUBM Advanstar logo